Biotechnology: bearing the hopes of cure of millions of patients but suffering in the current economic environment.

- How will the biotech & pharma industry get through the current crisis ?
- How can collaborations and partnerships reduce risk and improve the success rates ?
- How to boost the drug discovery and development process ?
- What is the way forward to deliver innovative treatments to patients ?

BioFirst - Presentation of the Ernst & Young Biotech Report
26 June 2012, 18:00 at the Merck Serono Biotech Center in Corsier-sur-Vevey
followed by a networking cocktail reception at 19:30


For the 6th consecutive year, Merck Serono will be hosting and co-organizing with Rezonance et Ernst & Young a BioFirst conference, built around Ernst & Young's "Beyond Borders 2011 Global Biotech Report” that will be issued mid-June.


This BioFirst will take the pulse of the industry and distinguished guests from the Swiss biotech community will provide insights into these questions.


Presentation of the Ernst & Young's "Beyond Borders 2011 Global Biotech Report” Jürg Zürcher and Mark Hawkins, Ernst & Young


Panel discussion:

  • Philippe Lopes-Fernandes, Vice President, Global Business Development, Merck Serono
  • David Deperthes, Business Development & Licensing Director, Debiopharm
  • Prof. Florian Wurm, EPFL and Founder, CSO and interim CEO of ExcellGene
  • Jürg Zürcher, Biotech Industry Leader for EMEIA, Ernst & Young
  • Mark Hawkins, Partner Audit Services, Ernst & Young

 

Important note : for logistical reasons registration to this event is required. Registrations are open until Friday, June 22 on www.rezonance.ch/ft/agenda

URL

 

 

Find an actor

4à6 de BioAlps - Stryker14.12.2017

Bilan - Les Métiers de Demain

Le magazine référence nous informe des nouvelles formations et de leur impact sur l'avenir des métiers de la santé...
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn